Net profit of Glenmark Pharmaceuticals rose 96.81% to Rs 595.06 crore in the quarter ended September 2024 as against Rs 302.35 crore during the previous quarter ended September 2023. Sales rose 19.56% to Rs 2594.89 crore in the quarter ended September 2024 as against Rs 2170.40 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 2594.89 | 2170.40 | 20 |
| OPM % | 30.01 | 20.43 | - |
| PBDT | 849.91 | 458.89 | 85 |
| PBT | 795.06 | 409.04 | 94 |
| NP | 595.06 | 302.35 | 97 |